Potential Therapeutic Applications of Adenosine A<sub>2A</sub>Receptor Ligands and Opportunities for A<sub>2A</sub>Receptor ImagingAren van Waarde, Philip H. Elsinga, Rudi Dierckx et al.|Medicinal Research Reviews|2017Cited by 42
Synthesis and Preclinical Evaluation of 2-(2-Furanyl)-7-[2-[4-[4-(2-[<sup>11</sup>C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7<i>H</i>-pyrazolo[4,3-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidine-5-amine ([<sup>11</sup>C]Preladenant) as a PET Tracer for the Imaging of Cerebral Adenosine A<sub>2A</sub> ReceptorsXiaoyun Zhou, Philip H. Elsinga, Rolf Zijlma et al.|Journal of Medicinal Chemistry|2014Cited by 34
Development of [<sup>18</sup>F]-Labeled Pyrazolo[4,3-<i>e</i>]-1,2,4- triazolo[1,5-<i>c</i>]pyrimidine (SCH442416) Analogs for the Imaging of Cerebral Adenosine A<sub>2A</sub>Receptors with Positron Emission TomographyShivashankar Khanapur, Philip H. Elsinga, Soumen Paul et al.|Journal of Medicinal Chemistry|2014Cited by 33
In vivo evaluation of [ <sup>11</sup> C]preladenant positron emission tomography for quantification of adenosine A <sub>2A</sub> receptors in the rat brainXiaoyun Zhou, Erik F. J. de Vries, Shivashankar Khanapur et al.|Journal of Cerebral Blood Flow & Metabolism|2016Cited by 22
Radiation Dosimetry of a Novel Adenosine A2A Receptor Radioligand [11C]Preladenant Based on PET/CT Imaging and Ex Vivo Biodistribution in RatsXiaoyun Zhou, Johan R. de Jong, Philip H. Elsinga et al.|Molecular Imaging and Biology|2016Cited by 21